JSR Life Sciences, LLC: Similis Bio Partners With Novel351k

JSR Life Sciences, LLC ("JSR") today announced that Similis Bio ("Similis"), its business unit focused on biosimilar development, has announced plans to enter into a partnership with Novel351k to co-develop

Related Keywords

Dennis Riedl , John Gabrielson , Sarfaraz Niazi , Similis Bio , Missy Bindseil , Keara Sauber , Laura Morgan , Crown Bioscience , Life Science , Life Sciences Similis Bio , Life Sciences Media Inquiries , Jsr Life Sciences , Sam Brown Inc , Biopharma Inc , Marketing Communications , Life Sciences , Life Sciences Company Inquiries , Senior Vice President , Chief Scientific Officer , Sciences Company Inquiries , Sciences Media Inquiries , Life , Ciences , Similis , Partners , Ith , Novel351k , Evelop , Multiple , Biosimilar , Programs , Targeting , Dancer , Autoimmune , Diseases ,